Not applicableLooking for participantsNCT07247227What this trial is testingReal-world First-line Sugemalimab-Chemotherapy in Advanced NSCLCWho this might be right forNSCLC Peking Union Medical College 150
Large-scale testing (Phase 3)Looking for participantsNCT04928846What this trial is testingAssess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)Who this might be right forNon Small Cell Lung Cancer AbbVie 768
Early research (Phase 1)UnknownNCT04448379What this trial is testingEfficacy and Safety of JMT101 Combined With Afatinib (or Osimertinib) in Patients With Non-Small Cell Lung CancerWho this might be right forLocally Advanced or Metastatic Non-Small Cell Lung Cancer Shanghai JMT-Bio Inc. 48
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06182761What this trial is testingSunvozertinib Combined With Anlotinib in Local Advanced or Metastatic Non-small Cell Lung CancerWho this might be right forNSCLC Shanghai Zhongshan Hospital 45
Testing effectiveness (Phase 2)Ended earlyNCT04032704What this trial is testingLadiratuzumab Vedotin in Advanced Solid TumorsWho this might be right forSmall Cell Lung CancerNon-small Cell Lung Cancer, SquamousNon-small Cell Lung Cancer, Non-squamous+6 more Seagen Inc. 205
Early research (Phase 1)Active Not RecruitingNCT05581004What this trial is testingEvaluate the Safety, Pharmacokinetics, and Activity of Enzelkitug as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid TumorsWho this might be right forLocally Advanced or Metastatic Solid TumorsNSCLCHNSCC+9 more Genentech, Inc. 165
Testing effectiveness (Phase 2)Looking for participantsNCT07206498What this trial is testingEvaluate Safety and Efficacy of WSD0922-FU Combo With Osimertinib for NSCLCWho this might be right forNon Small Cell Lung Cancer (NSCLC) Wayshine Biopharm, Inc. 48
Testing effectiveness (Phase 2)Study completedNCT00777309What this trial is testingPhase 2 Study of Erlotinib + ARQ 197 Versus Erlotinib + Placebo in Previously Treated Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)Who this might be right forNon Small Cell Lung Cancer ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) 167
Testing effectiveness (Phase 2)UnknownNCT05900219What this trial is testingEfficacy and Safety of HL-085 Combined With Vemurafenib in BRAF V600E Patients With Non-small Cell Lung Cancer: a Phase II Clinical StudyWho this might be right forNon-small-cell Lung Cancer Shanghai Kechow Pharma, Inc. 75
Testing effectiveness (Phase 2)Looking for participantsNCT07489716What this trial is testingA Phase II Clinical Trial of SHR-1826 for Non-Small Cell Lung CancerWho this might be right forNon-Small Cell Lung Cancer Suzhou Suncadia Biopharmaceuticals Co., Ltd. 90
Testing effectiveness (Phase 2)Study completedNCT01846416What this trial is testingAtezolizumab in Participants With Programmed Death-Ligand 1 (PD-L1) Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) [FIR]Who this might be right forNon-Small Cell Lung Cancer Genentech, Inc. 138
Testing effectiveness (Phase 2)Ended earlyNCT00522938What this trial is testingClinical Trial of the Safety and Effectiveness of CHR-2797 With Erlotinib in Patients With Locally Advanced or Metastatic Non-small Cell Lung CancerWho this might be right forCarcinoma, Non-Small-Cell Lung Chroma Therapeutics 2
Early research (Phase 1)Looking for participantsNCT07390838What this trial is testingSH009 Injection in Patients With Advanced Solid Tumors.Who this might be right forLiver Cancer (Locally Advanced or Metastatic)Lung Cancer (NSCLC)Head and Neck Cancer Squamous Cell Carcinoma+4 more Nanjing Sanhome Pharmaceutical, Co., Ltd. 150
Not applicableApproved For MarketingNCT01649284What this trial is testingAfatinib Expanded Access ProgramWho this might be right forCarcinoma, Non-Small-Cell Lung Boehringer Ingelheim
Testing effectiveness (Phase 2)UnknownNCT05519293What this trial is testingPhase I/IIa Study of H002 in NSCLC With Active EGFR MutationWho this might be right forNon-small Cell Lung Cancer RedCloud Bio 76
Testing effectiveness (Phase 2)Ended earlyNCT02546986What this trial is testingSafety and Efficacy Study of CC-486 With MK-3475 to Treat Locally Advanced or Metastatic Non-small Cell Lung CancerWho this might be right forCarcinoma, Non-Small-Cell Lung Celgene 100
Large-scale testing (Phase 3)Active Not RecruitingNCT04035486What this trial is testingOsimertinib With or Without Chemotherapy as 1st Line Treatment in Patients With Mutated Epidermal Growth Factor Receptor Non-Small Cell Lung Cancer (FLAURA2)Who this might be right forNon-Small Cell Lung Cancer AstraZeneca 587
Not applicableStudy completedNCT05862194What this trial is testingRetrospective, External Comparator Study of Lazertinib as the 2nd-Line Treatment in Patients With EGFR Mutation+ NSCLCWho this might be right forNon-small Cell Lung Cancer Yuhan Corporation 534
Early research (Phase 1)Looking for participantsNCT04297605What this trial is testingStudy of Pembrolizumab and Single Agent Chemotherapy as First Line Treatment for Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer With Eastern Cooperative Oncology Group (ECOG) Performance Status of 2Who this might be right forNon-small Cell Lung Cancer University of Rochester 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07742956What this trial is testingPhase II Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Antitumor Activity of ALK201 for Injection in Combination With Ivonescimab Injection in sqNSCLC Participants.Who this might be right forNSCLC (Advanced Non-small Cell Lung Cancer) Shanghai Allink Biotherapeutics Co., Ltd. 156